Immunogenicity assessment strategy for a chemically modified therapeutic protein in clinical development.
针对处于临床开发阶段的化学修饰治疗蛋白的免疫原性评估策略
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1438251
Hagman Charlotte, Chasseigne Gaetan, Nelson Robert, Anlauff Florian, Kagan Mark, Goldfine Allison B, Terszowski Grzegorz, Jadhav Maria
